Senescent CD8+ T cells: a novel risk factor in atrial fibrillation
Cardiovascular Research · 2025
DOI: 10.1093/cvr/cvae222 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cardiovascular Research, 2025. Verfasst von Xiang Li und 17 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiovascular Medicine, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, No. 197, Ruijin Road Number Two, Shanghai 2…. Hauptthemen laut MEDLINE: Atrial Fibrillation, CD8-Positive T-Lymphocytes, Cellular Senescence, Immunosenescence. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 33 Literaturangaben. Gefördert von: Shanghai Municipal Education Commission, Gaofeng Clinical Medicine, Clinical Research Plan for Shanghai Hospital Development Center.
Abstract (Originalsprache)
Aims
Immune cell alterations may play a role in the development of atrial fibrillation (AF). Our objective was to comprehensively characterize immune cells in AF, and investigate the potential mechanisms. Methods and results Single-cell RNA sequencing and multicolour flow cytometry revealed that T cells constituted the most significant subset alterations in AF, and senescent CD8+ T cells were AF-associated subset. Senescent CD8+ T cells increased in both peripheral veins (P < 0.0001) and the left atria (P < 0.05) in patients with AF compared to non-AF control. Senescent CD8+ T cells were independently associated with AF prevalence (odds ratio = 2.876, P < 0.05) and postprocedural recurrence (hazard ratio = 22.955, P < 0.0001) using a cross-sectional study and a subsequent prospective cohort study. Senescent CD8+ T cells secreted an increased amount of interferon (IFN)-γ, which induces Ca2+ handling abnormalities in human induced pluripotent stem cell-derived atrial cardiomyocytes, and translated into an increased susceptibility to AF assessed by heart optical mapping.
Conclusions
An increased amount of senescent CD8+ T cells may be a hallmark of the immune senescence phenotype in AF and potentially serve as a valid biomarker for assessing prevalence and postprocedural recurrence of AF. By connecting immune senescence with electrophysiological disturbances in AF, this research provides a potential mechanism for the involvement of senescent CD8+ T cells in proarrhythmic calcium disorders and suggests novel avenues for developing new immune-modulatory and senolytic therapies for AF.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Cardiovascular Medicine, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, No. 197, Ruijin Road Number Two, Shanghai 200025, China.
- Institute of Cardiovascular Diseases, Shanghai Jiao Tong University School of Medicine, No. 197, Ruijin Road Number Two, Shanghai 200025, China.
ORCID-Profile: Qi Jin
Förderung
- Shanghai Municipal Education Commission
- Gaofeng Clinical Medicine
- Clinical Research Plan for Shanghai Hospital Development Center
- National Natural Science Foundation of China
Zitieren
APA
Li, X., Bao, Y., Zhang, N., Lin, C., Xie, Y., Wei, Y., Luo, Q., Liu, J., Sha, Z., Wu, G., Zhou, T., Chen, Q., Ling, T., Pan, W., Lu, L., Wu, L., Dai, Y., & Jin, Q. (2025). Senescent CD8+ T cells: a novel risk factor in atrial fibrillation. Cardiovascular Research. https://doi.org/10.1093/cvr/cvae222
Vancouver
Li X, Bao Y, Zhang N, Lin C, Xie Y, Wei Y, et al. Senescent CD8+ T cells: a novel risk factor in atrial fibrillation. Cardiovascular Research. 2025. doi:10.1093/cvr/cvae222
BibTeX
@article{Li2025,
author = {Li, Xiang and Bao, Yangyang and Zhang, Ning and Lin, Changjian and Xie, Yun and Wei, Yue and Luo, Qingzhi and Liu, Jingmeng and Sha, Zimo and Wu, Guanhua and Zhou, Taojie and Chen, Qiujing and Ling, Tianyou and Pan, Wenqi and Lu, Lin and Wu, Liqun and Dai, Yang and Jin, Qi},
title = {Senescent CD8+ T cells: a novel risk factor in atrial fibrillation},
journal = {Cardiovascular Research},
year = {2025},
doi = {10.1093/cvr/cvae222}
}
EUVIMED